Brazil
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.56 B
|
Dec. 31, 2023 | USD 4.80 | 0.53% |
|
Brazil |
|
2 |
USD 799.56 M
|
Dec. 31, 2023 | USD 0.31 | -1.64% |
|
Brazil |
|
3 |
USD 363.29 M
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
4 |
USD 326.68 M
|
Dec. 31, 2023 | USD 2.04 | 0.87% |
|
Brazil |
|
5 |
USD 95.51 M
|
Dec. 31, 2023 | USD 2.21 | -0.40% |
|
Brazil |
|
6 |
USD 75.04 M
|
Dec. 31, 2023 | USD 1.95 | -3.23% |
|
Brazil |
|
7 |
USD 21.16 M
|
Dec. 31, 2023 | USD 1.97 | 2.04% |
|
Brazil |
|
8 |
USD 2.42 M
|
Dec. 31, 2023 | USD 1.66 | 0.01% |
|
Brazil |
The Biotechnology company in Brazil with the highest Gross Profit is Rede D'Or São Luiz S.A. (São Paulo Stock Exchange: RDOR3.SA) at USD 1.56 B.
The Biotechnology company in Brazil with the lowest Gross Profit is Biomm S.A. (São Paulo Stock Exchange: BIOM3.SA) at USD 2.42 M.
The top 10 Biotechnology companies in Brazil by Gross Profit are Rede D'Or São Luiz S.A., Diagnósticos da América S.A., Afya Limited, Fleury S.A., Blau Farmacêutica S.A., Centro de Imagem Diagnósticos S.A., Baumer S.A. and Biomm S.A..
The bottom 10 Biotechnology companies in Brazil by Gross Profit are Biomm S.A., Baumer S.A., Centro de Imagem Diagnósticos S.A., Blau Farmacêutica S.A., Fleury S.A., Afya Limited, Diagnósticos da América S.A. and Rede D'Or São Luiz S.A..